title: [The longsurvivors for non-small cell lung cancer: remarks on the present and in perspective].
abstract: The Authors fully share cricitisms voiced in international literature to NSCLC longsurvivors, in particular those remarkes related to advanced disease patients following various anti-tumor treatments ( mostly multimodal). To this point, even the NCCN version 3.2014 guidelines prove inadequate as they mostly focus on longsurvivors post-NSCLC early stage surgical resection. Although AIOM Working Group's recommendations for follow-up seem to be more adequate, still they lack depth with respect to advanced-stage bronchogenic carcinoma. The Authors quote a number of case report related to advanced disease longsurvivors, and draws his attention on the peculiar role of pneumologists in the follow-up for such patients: in particular, as regards respiratory pathologies prior or subsequent to different anti-tumor treatments (i.e., BPCO, interstitial lung diseases, pulmonary thromboembolism, etc.).
authors.affiliation: FONICAP (Forza Operativa Nazionale Interdisciplinare Contro il Cancro al Polmone).
authors.forename: F
authors.initials: F
authors.lastname: Salvati
authors.affiliation: U.O. Pneumoncologia 2.
authors.forename: M
authors.initials: M
authors.lastname: Signora
authors.affiliation: U.O. Chirurgia Toracica, Azienda Ospedaliera San Camillo - Forlanini, Roma, Italia.
authors.forename: G
authors.initials: G
authors.lastname: Cardillo
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007558:Italy; D008175:Lung Neoplasms / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D016019:Survival Analysis; D017741:Survivors
keywords: Advanced disease; Bronchogenic carcinoma; Follow-up; Longsurvivors; Non-small cell cancer